During the past decade, Bay State Clinical Trials, Inc. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 16 clinical trials were completed, i.e. on average, 84.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bay State Clinical Trials, Inc." #1 sponsor was "Urovant Sciences GmbH" with 6 trials, followed by "Allergan" with 3 trials sponsored, "Ferring Pharmaceuticals" with 3 trials sponsored, "GTx" with 3 trials sponsored and "Bay State Clinical Trials, Inc." with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bay State Clinical Trials, Inc." #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "TARIS Biomedical, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Bay State Clinical Trials, Inc." are "Overactive Bladder" (7 trials), "Nocturia" (4 trials), "Prostate Cancer" (3 trials), "Stress Urinary Incontinence" (3 trials) and "Chronic Idiopathic Constipation" (2 trials). Many other conditions were trialed in "Bay State Clinical Trials, Inc." in a lesser frequency.

Most popular intervention types in "Bay State Clinical Trials, Inc." are "Drug" (30 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Vibegron" (4 trials), "Desmopressin" (3 trials), "GTx-024" (2 trials) and "Tolterodine Tartrate ER" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bay State Clinical Trials, Inc." are 18 trials for "All" genders, 8 trials for "Male" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Bay State Clinical Trials, Inc.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Bay State Clinical Trials, Inc., 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Bay State Clinical Trials, Inc., 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".